InvestorsHub Logo
Followers 21
Posts 1073
Boards Moderated 0
Alias Born 12/12/2016

Re: None

Thursday, 03/21/2024 11:52:06 AM

Thursday, March 21, 2024 11:52:06 AM

Post# of 691895
KEYTRUDA did not YET AGAIN meet its dual primary endpoints of overall survival (OS) and progression-free survival (PFS)



.
Bullish
Bullish

Potential CURE for cancer - DCVax could well be the biggest medical breakthrough - EVER

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News